SGX Nifty:
Trading of Nifty 50 index futures on the Singapore stock exchange indicates that the Nifty could rise 42 points at the opening bell.
Global markets:
Overseas, Asian stocks are trading higher on Wednesday after U.S. shares closed at a record on economic optimism and signs that vaccines can counter a highly infectious coronavirus strain.
China's official manufacturing Purchasing Manager's Index (PMI) grew at a slower clip in June. The reading eased to 50.9 in June from 51 in May.
Japan's industrial output posted the biggest monthly drop in a year in May. Factory output slumped 5.9% in May from the previous month, official data showed on Wednesday, hit by declines in the manufacturing of cars and production machinery to post its largest monthly drop since May last year.
The S&P 500 and Nasdaq 100 edged higher to close at new records on Tuesday, continuing their four-day win streak even as investors grow anxious about the increased spread of the Delta variant of COVID-19.
Meanwhile, Moderna said Tuesday its Covid-19 vaccine showed promise in a lab setting against coronavirus variants, including the highly contagious delta variant first identified in India. Moderna said its vaccine was authorized for use in India, where the delta variant is thought to be behind the large outbreak there.
Domestic markets:
Back home, the key equity indices ended with modest losses on Tuesday. The barometer index, the S&P BSE Sensex, fell 185.93 points or 0.35% to 52,549.66. The Nifty 50 index lost 66.25 points or 0.42% to 15,748.45.
Foreign portfolio investors (FPIs) bought shares worth Rs 116.63 crore, while domestic institutional investors (DIIs), were net buyers to the tune of Rs 1,810.05 crore in the Indian equity market on 29 June, provisional data showed.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU